(1)
A person consulted under section 23(3)(b) may raise with the Director-General the question of whether scientific evidence about which the person raised a significant concern received sufficient regard in the development of the standard.
(2)
The Director-General must ensure that there is a process to establish an independent review panel to review the question of whether scientific evidence about which a person has raised a significant concern received sufficient regard in the development of the standard.
(3)
The process must deal with—
the criteria for setting up the panel; and
how the Director-General will appoint the panel members, including the knowledge and experience that members must have; and
the procedures to be followed by—
a person consulted under section 23(3)(b); and
the panel in undertaking its review; and
the reporting requirements for the panel.
(4)
If a panel reports to the Director-General, the Director-General must, as soon as reasonably practicable,—
take the panel’s findings and recommendations into account; and
determine the issue in dispute; and
give reasons for the determination.
Section 24: replaced, on 18 September 2012, by section 20 of the Biosecurity Law Reform Act 2012 (2012 No 73).